Abstract
Nanoparticles (NPs) can be developed to improve drug penetration and reorient chemotherapy, or selectively target the cancer cells or cell compartment. Both passive and active targeting strategies are used to redirect the anticancer drugs. Noble metals such as the silver NPs (AgNPs) are characterized by electrical, optical, and thermal properties, and can be integrated into products for optical, biological and chemical sensor applications such as pastes, conductive inks, and fillers for high stabilization, electrical conductivity, and low sintering temperatures. The biosynthesis of AgNPs, making use of bacteria, fungi, actinomycetes, yeast, algae, and plants, is eco-friendly, green, nontoxic and inexpensive. The AgNPs sytnhesized are of various shapes and sizes. The AgNPs have diverse bioactivities including antibacterial, antifungal, antiviral, anti-inflammatory, anti-angiogenic, and anticancer activities, with great potential for use in cancer diagnosis and therapy. The mechanisms of AgNP-induced cytotoxicity include endoplasmic reticulum stress, lactate dehydrogenase leakage, and enhanced reactive oxygen species level. Co-application of AgNPs and natural products could play an essential role in nanoscience and nanotechnology, especially in nanomedicine for cancer diagnosis and therapeutics.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
14.1 Introduction
Nanoparticles (NPs) and nanomaterials can be utilized for human medical applications, including for the delivery of therapeutic drugs to cells, or for the imaging of tissues and organs. NPs are divided into organic and inorganic materials. Organic NPs include the carbon NPs (fullerenes) and inorganic NPs include the magnetic, noble metals (such as gold and silver) and semi-conductive (such as titanium dioxide and zinc oxide) NPs. The inorganic NPs have superior material features with functional versatility and have potential for application in imaging tools as well as for disease treatment owing to their sizes and their benefits as pharmaceutical agents and chemotherapy drugs. Mesoporous silica is established along with the molecular machinery to be used for imaging and as release systems. NPs have been used successfully for the delivery of therapeutic agents (Zhang et al. 2008), in diagnostics for chronic diseases (Hong et al. 2008), and the treatment of bacterial skin infections and burn wounds (Rai et al. 2009). Gold NPs are widely used in imaging, as drug carriers, and in the thermal treatment of biological targets (Cheon and Underwood 2009). The bactericidal behavior of NPs is attributed to the presence of electronic effects as a result of changes in the local electronic structure of the surface owing to their smaller sizes. The NPs become attached to the cell membrane and penetrate inside the bacteria.
Several NPs that are loaded with drugs interact with the organs and tissues and are eventually taken up by the cells. The tissue, cell and cell organelle distribution of the drugs can therefore be controlled and improved by entrapping them into the colloidal NPs, such as the nanocontainer or nanocarrier (Minchinton and Tannock 2006; De Jong and Borm 2008; Zhang et al. 2013). However, not all nanocarriers penetrate tumor tissue (Lammers et al. 2012). Nanomedicine compounds can be designed to improve drug penetration and reorient the chemotherapy or target the cancer cells or cell compartment with the compounds selectively. Both negative and effective targeting strategies are used to redirect the anticancer drugs (Wicki et al. 2015). The nanomedicine treatments can increase the circulatory time of the compound and mediate the release of stimulant-responsive drugs as well as the absorption of the stimulant medication. This may result in reduced tumor cell resistance against targeted NPs (Huwyler et al. 2002; Hu and Zhang 2009). NP drug delivery systems have great advantages such as delivery through the smallest capillary vessels owing to their small sizes and avoiding fast clearance by phagocytes, infiltration of the cells and tissue gap to reach the target site. Existing controlled release features such as the pH, ion, and/or temperature sensitivity of the substance can improve the efficacy of the drugs, whilst minimizing the toxic side effects (Zhang et al. 2010a, b).
Nanobiotechnology combines the nanotechnology area with microbiology, chemistry and physical sciences, and the synthesis of NPs by utilizing the biological systems such as plants, bacteria, and fungi (Ahmad et al. 2003; Prasad 2014; Prasad et al. 2016, 2018). NPs exhibit new or improved properties based on the specific characteristics such as size, distribution, and morphology, resulting in rapid and tunable applications of the NPs and nanomaterials (Dakhil 2017). The common methods for the synthesis of NPs include physical and chemical approaches using laser ablation, pyrolysis, lithography, chemical vapor deposition, sol-gel techniques, and electro-deposition, but these are expensive and hazardous (Vijayakumar et al. 2013). Different reactants are used, especially reducing agents such as sodium borohydride (Kim et al. 2007), potassium bitartrate (Tan et al. 2003), methoxypolyethylene glycol (Zewde et al. 2016), and hydrazine (Li et al. 1999). It also requires a stabilizing agent such as sodium dodecyl benzyl sulfate or polyvinyl pyrrolidone to prevent the agglomeration of metallic NPs. Generally, the chemical methods are low-cost for high volume, but may involve contamination from the precursor chemicals, the use of toxic solvents, and the generation of hazardous by-products (Thakkar et al. 2010).
There is an increasing need to develop simple, cost-effective, high-yield, and eco-friendly procedures (Gurunathan et al. 2013a, b). The alternative green method for the biosynthesis of metal NPs is via the living organisms or material of biological origin. NPs can be synthesized by using living bacteria or fungi, or plant extracts, which is environmentally friendly, takes place around room temperature or lower, and requires little intervention or input of energy (Dash 2013). The important three factors are: (a) the solvent, (b) the reducing agent, and (c) the nontoxic material. The availability of amino acids, proteins, or secondary metabolites could facilitate the synthesis process, prevent particle aggregation, and is pollution-free. The biological methods using bacterial protein or plant extracts as reducing agents allow control of the particle size, shape, and monodispersity of the NPs, which are important for various biomedical applications (Gurunathan et al. 2009, 2014). The availability of a vast array of biological resources, a decreased time requirement, high density, stability, and the ready solubility of the prepared NPs in water (Thakkar et al. 2010), confer major advantages over the chemical synthetic route of other metallic-based anticancer agents (Caroling et al. 2013; Chaudhari et al. 2012; Yazdi et al. 2015; Jaffat et al. 2017). Many microbes, both unicellular and multicellular, produce inorganic materials, either intra- or extracellularly. Bacteria, yeast, and fungi play important roles in the remediation of toxic metals through the reduction of metal ions and act as nanofactories (Prasad et al. 2016). These microbes are extremely good candidates in the synthesis of cadmium, gold, and silver nanoparticles (AgNPs; Table 14.1) (Jeevan et al. 2012). Extracellular synthesis of NPs occurs outside the bacterial cell. These NPs, spherical, disk, cuboidal, hexagonal, or triangular shaped, have been synthesized using cells, culture supernatant, or aqueous cell-free extract (Klaus et al. 1999; Srivastava and Constanti 2012; Oves et al. 2013; Singh et al. 2013). The NPs are collected as pellets, which can be dissolved in suitable solvent. The extracellular methods are more useful than the intracellular methods because of the ease of obtaining the NPs from the solution (Singh and Shedbalkar 2015).
14.2 Silver Nanoparticles
Silver nanoparticles (AgNPs) are important because of their unique properties (Klaus-Joerger et al. 2001). AgNPs have gained special interest over gold and copper NPs because of their surface plasmon resonance (SPR) energy, which is located away from the interband transition energy (El-sheekh and El-kassas 2016). Because of their catalytic, optical, electrical, and magnetic properties, AgNPs have applications in electronic components, biosensors, environmental remediation, antimicrobial and anticancer agents, cosmetic products, optical catalysis, drug delivery (Klaus-Joerger et al. 2001; Kasthuri et al. 2009; Dubey et al. 2010; Nabikhan et al. 2010; Nithya and Ragunathan 2012; Aziz et al. 2014, 2015, 2016, 2019; Hussein et al. 2020), spectrally selected coatings for solar energy absorption, intercalation material for electrical batteries, optical receptors, chemical catalysis, and bio-labeling (Kalimuthu et al. 2008). AgNPs have been used extensively in household utensils, health care industry, and in food storage, environmental, and biomedical applications such as antibacterial, antifungal, antiviral, anti-inflammatory, anticancer, and anti-angiogenic products (Fig. 14.1) (Zhang et al. 2016). The AgNPs-based products have been approved by a range of accredited bodies, including the US FDA, US EPA, SIAA of Japan, Korea’s Testing and Research Institute for the Chemical Industry, and the FITI Testing and Research Institute (Abou El-Nour et al. 2010).
14.2.1 Biosynthesis
Silver nanoparticles have been biosynthesized using methods including the chemical reduction of silver (Ag) ion in aqueous solution (Liz-Marzán and Lado-Touriño 1996), photo-reduction (Pileni 2000; Sun et al. 2001), thermal decomposition in organic solutions (Esumi et al. 1990), and laser radiation (Henglein 1993, 1998). However, these are expensive, unstable, and also the AgNPs are toxic and cause several side effects and may not be suitable for medical or pharmaceutical purposes (Omidi et al. 2014). The development of biomedical applications has led to the need for a more reliable, nontoxic, and eco-friendly methods of NP synthesis (Braydich-Stolle et al. 2005). Although the log time of used AgNPs has been established, the evidence for silver toxicity is still not clear (Abou El-Nour et al. 2010). Figure 14.2 shows the proposed mechanism of bacteria-mediated synthesis of AgNPs: (a) cellular uptake of silver ions and activation of silver reduction machinery, (b) electron shuttle system involving various cofactors and enzymes, (c, d) intra- or extracellular localization of AgNPs, (e) electrostatic interaction between silver ions and the cell wall components, and (f) reduction through extracellular enzymes and other organic molecules released in the solution (Singh and Shedbalkar 2015). The bacteria may use nitrate anion (NO3-) as a source of nitrogen, leaving behind the metallic Ag ion (Dash 2013). The extracellular synthesis of AgNPs using Lactobacillus species is low-cost and effective (Chaudhari et al. 2012). For intracellular synthesis, the bacterial cells are added to the culture medium containing the silver salt and incubated at proper conditions of growth, and the cells are resuspended in sterile distilled water before challenging with silver salt to avoid contamination by the media components (Singh and Shedbalkar 2015). To obtain AgNPs using intracellular methods, the cells are ultrasonicated (Kalishwaralal et al. 2010). Heat treatment such as autoclaving and the detergents and salts can also be employed to lyse the cells (Fesharaki et al. 2010; Krishnamurthy and Yun 2013). Hence, it is more complicated than the extracellular method.
14.2.2 Characterization
The characterization of NPs is important in understanding and controlling the NP synthesis and applications. Different techniques such as transmission and scanning electron microscopy (TEM, SEM), atomic force microscopy (AFM), dynamic light scattering (DLS), X-ray photoelectron spectroscopy, powder X-ray diffractometry (XRD), Fourier transform infrared spectroscopy, and ultraviolet–visible (UV–Vis) spectroscopy are used to characterize the NPs (Abou El-Nour et al. 2010). The parameters to be determined are the particle size, shape, crystallinity, fractal dimensions, pore size, surface area, orientation, intercalation, and the dispersion of NPs and nanotubes in the nanocomposite materials (Zewde et al. 2016). The morphology and particle size can be measured using TEM, SEM, and AFM. The DLS determines the particle size distribution. XRD is used for the determination of crystallinity, and UV–Vis spectroscopy is used to confirm the sample formation based on the plasmon resonance (Abou El-Nour et al. 2010).
14.2.3 Anti-microbial Activities
The antibiotic-resistant microbes have become a major global concern. It is important to develop newly effective antimicrobial agents that can overcome the multiple antibiotics resistance of the microorganisms (Franci et al. 2015). AgNPs are considered to be novel agents for antimicrobes (Vijayakumar et al. 2013), with good antimicrobial and antioxidant activities (Niraimathi et al. 2013), antifungal, anti-inflammatory, antiviral, anti-angiogenesis, and antiplatelet activities (Caroling et al. 2013). Low concentrations of AgNPs may have no cytotoxicity on human cells, but may be deadly for many viruses and bacteria. The AgNPs may possibly reduce the toxicity on the cells, without affecting the antibacterial efficacy (Karimzadeh and Mansour 2010).
The high antibacterial activity of AgNPs compared with other salts is attributable to their finely sharp surface and extremely large surface area. The antibacterial action of AgNPs (Fig. 14.3) has been proposed as follows:
-
(a)
The small AgNPs penetrate through the cell membrane and create pores to cause cellular leakage.
-
(b)
The intracellular processes are disturbed to provide better contact with microorganisms. The bacterial membrane contains sulfur-containing proteins and the AgNPs interact with these proteins in the cell as well as with the phosphorus-containing compounds such as DNA. Inside the bacterial cell, the AgNPs form a low-molecular-weight region in the center of the bacteria to which the bacteria conglomerates, thus protecting the DNA from the Ag ions.
-
(c)
The AgNPs break the dsDNA.
-
(d)
DNA replication is inhibited.
-
(e)
Interaction with 30S ribosome.
-
(f)
Inactivation of vital enzymes.
-
(g)
Protein is denatured.
-
(h)
Cellular signaling is modulated.
-
(i)
Reactive oxygen species (ROS) is generated, which acts on the DNA and cell membrane.
-
(j)
Ag ions are released, which affect the normal functioning of membrane proteins, and enhance their bactericidal activity. The AgNPs destabilize the plasma membrane potential and deplete the levels of intracellular adenosine triphosphate (ATP) by targeting the bacterial membrane.
-
(k)
Accumulation inside the cells in lethal concentrations results in bacterial cell death (Patil and Kim 2017).
The mechanisms of AgNP-induced cell death are observed in E. coli through the leakage of reducing sugars and proteins. The AgNPs destroy the permeability of the bacterial membranes via the generation of many pits and gaps, indicating the damage to the bacterial cell membrane structure (Dibrov et al. 2002; Li et al. 2010; Patil et al. 2012). The AgNPs have greater affinity for the interaction with phosphorous and sulfur-containing biomolecules found in the extracellular (membrane protein), and the intracellular components (DNA bases, protein), which are involved in cell division, respiration, and cell survival (Patil and Kim 2017). The Ag ions display antibacterial activity by interacting with the peptidoglycan cell wall and plasma membrane (Radzig et al. 2013) and also by inhibiting bacterial DNA replication through the reaction with sulfhydryl groups in the protein (Seth et al. 2011). The Ag ion can damage the protein structures of the bacteria by binding to the thiol and amino groups (Choi et al. 2008). The interaction of the NPs with the thiol group leads to the stimulation of ROS, resulting in the inhibition of respiratory enzymes and then cell death (Holt and Bard 2005; Ninganagouda et al. 2014).
The AgNPs biosynthesized by using Abutilon indicum leaf extract exhibit greater antibacterial effects (inhibition zone diameter) on Staphylococcus aureus (16.8 mm), Bacillus subtilis (18.3 mm), Salmonella typhi (14.5 mm), and Escherichia coli (17.2 mm) (Ashokkumar et al. 2015). The inoculation of Ipomea carnea-AgNPs on a cellulose acetate membrane exhibits a 14 mm inhibition zone against Mycobacterium smegmatis (Daniel et al. 2014). The AgNPs synthesized by Boerhavia diffusa show greater sensitivity on Flavobacterium branchiophilum compared with two other fish bacterial pathogens Aeromonas hydrophila and Pseudomonas fluorescens (Thakur et al. 2014). Lingo-berry- and cranberry juice-mediated AgNPs show a higher level of activity against S. aureus, B. subtilis, and B. cereus, but a low level of activity against C. albicans and food-borne B. cereus (Firdhouse and Lalitha 2015). The biosynthesized AgNPs using cell-free supernatants of Staphylococcus aureus exhibit significant antimicrobial activity against methicillin-resistant S. aureus, followed by methicillin-resistant Staphylococcus epidermidis and Streptococcus pyogenes, but with only moderate effects against Salmonella typhi and Klebsiella pneumoniae (Nanda and Saravanan 2009). The AgNP-mediated Broccoli floret aqueous extract are effective against human pathogens such as Klebsiella pneumonia, Staphylococcus saprophyticus, and Escherichia coli (Caroling et al. 2013). The AgNPs become attached to the surface of the cell membrane, disturb the function, and penetrate directly into the bacterial outer membrane and release the Ag ions (Caroling et al. 2013).
14.2.4 Anti-cancer Activities
The discovery and identification of a new antitumor drug with few side effects on the immune system has become major goal in many studies on immuno-pharmacology (Xu et al. 2009). The focus has increased towards developing potent anticancer and antitumor drugs based on the natural compounds from plants and marine bioresources and microorganisms (Devi et al. 2012). Most cytotoxic drugs act on cancer cell growth and division, but the co-application with nanomaterials could revolutionize cancer diagnosis and therapy (Abdullah et al. 2014; Gul-e-Saba and Abdullah 2015; Supraja et al. 2016; Hussein et al. 2020) and the encapsulation of therapeutic agents with NPs could improve targeted drug delivery systems (Abdullah et al. 2014). The use of metallic NPs and medical AgNPs has shown different degrees of in vitro cytotoxicity with the ability for passive or active targeting on any particular diseased cells or tumor tissues (Wicki et al. 2015). To overcome the limitations of conventional chemotherapy, the challenges will be to develop new NPs in single platform-based strategies and to address the physiological barriers, limited carrying capacity, enhanced permeability and retention effect (EPR), the variability of NPs, and the regulatory and manufacturing issues (Wicki et al. 2015).
Although AgNPs may have low toxicity towards human cells with high thermal stability (El-Kassas and El-Sheekh 2014), the toxicity can be influenced by the availability of chemical, biochemical, and/or biological coatings on the NPs surface (Suresh et al. 2012). The surface charges of the AgNPs could determine the toxicity effects in the cells. The positive surface charge may make the cells more adaptable, allowing them to stay for a long time in the blood stream, as compared to the negatively-charged NPs (Tabata and Ikada 1988). This is pertinent for the regulation of anticancer agent (Tiyaboonchai 2003; Schlinkert et al. 2015). The AgNPs may interact with the thiol-rich enzymes, overlapping with the suitable functioning of the cellular proteins, and inducing changes in the cellular chemistry such as providing relatively high hydrophobicity inside the bovine hemoglobin, which causes a transition from alpha helices to beta sheets, leading to partial unfolding and the aggregation of protein (Shawkey et al. 2013; Supraja and Arumugam 2015). The anticancerous efficacies of the AgNPs synthesized through different sources have been evaluated against the Hep2 cell line (Devi et al. 2012; Rosarin et al. 2013), the HT-29 cell line, the Vero cell line, and breast cancer line MCF-7 (Devi and Bhimba 2012; Hussein et al. 2020). AgNPs synthesized using Acalypha indica Linn. exhibit only 40% cell inhibition toward human breast cancer cells (MDA-MB-231) (Krishnaraj et al. 2014). The viability of MCF-7 cells is also reduced to 50% at 5 μg/mL when treated with AgNPs biosynthesized by Dendrophthoe falcata (L.f) Ettingsh (Sathishkumar et al. 2014).
The AgNPs synthesized using Aloe, Magnolia leaves, and Eucalyptus leaves extracted at 2–4 ppm are found to be noncytotoxic to human embryonic kidney 293 cells, as analyzed by the automated InQ Plus equipment (Okafor et al. 2013). The stem latex of Euphorbia nivulia-capped AgNPs solubilize in water and act as a biocompatible vehicle for the transport of nanosilver to human lung carcinoma cells (A549) (Valodkar et al. 2011). No cytotoxicity effects of Aloe vera-conjugated AgNPs have been observed against human dermal fibroblasts (HDF) cells, but excellent antibacterial activity is reported against E. coli even at very low concentration (Zhang et al. 2010a, b). The Chrysanthemum indicum-AgNPs also exhibit no toxicity on 3T3 mouse embryo fibroblast cells at 25 μg/mL (Arokiyaraj et al. 2014). The AgNPs synthesized using Origanum vulgare exhibit a higher dose-dependent response toward human lung A549 cancer cell line (LD50 100 μg/mL) (Sankar et al. 2013). The AgNPs biosynthesized using Albizia adianthifolia leaf extract at 10 and 50 μg/mL, show reduced viability of A549 cells to 21%, and 73%, and the normal peripheral lymphocytes to 117% and 109%, respectively, after 6 h exposure. This suggests that the AgNPs are potentially nontoxic to the normal healthy peripheral lymphocytes (PLs) (Gengan et al. 2013). However, the AgNPs synthesized using the root of Morinda citrifolia exhibit 100% cell death against the HeLa cell line at 100 μg of AgNPs (Suman et al. 2013).
The IC50 of A549 cells is at 43 μg/mL after AgNP treatment, which induces the cell death by ROS generation, resulting in apoptosis (Govender et al. 2013). The MCF-7 cells treated with Sesbania grandiflora-mediated AgNPs at 20 μg/mL, lead to nuclear condensation, cell shrinkage, and fragmentation after 48 h, with Hoechst staining. These changes confirm the activation of DNA repair due to the cleavage of the substrates (Jeyaraj et al. 2013). The Ag (protein–lipid) nanoparticles (Ag-PL NPs) synthesized using Sterculia foetida (L.) seed extracts show cellular DNA fragmentation in HeLa cancer cell lines (Rajasekharreddy and Rani 2014). Alternanthera sessilis-mediated AgNPs at 25 μL/mL show complete apoptosis of about 95% against prostate cancer cells (PC3), whereas the growth of MCF-7 is inhibited almost 99% (Firdhouse and Lalitha 2013). Datura inoxia-AgNPs inhibit 50% of human MCF-7 proliferation at IC50 20 μg/mL after 24 h incubation by inhibiting its growth, arresting the cell-cycle phases, and reducing the DNA synthesis, to induce apoptosis (Gajendran et al. 2014). The anticancer effects of starch-coated AgNPs have been studied in the normal human lung fibroblast cells (IMR-90) and human glioblastoma cells (U251). The AgNPs show more sensitivity towards U251 cells than the IMR-90 cells by inducing changes in the cell morphology, reducing the cell viability and metabolic activity, and increasing the oxidative stress, leading to mitochondrial damage, increased ROS production, and DNA damage. The cellular uptake of the AgNPs occurs mainly through endocytosis, where the AgNP-treated cells show several abnormalities including upregulation of metallothionein, downregulation of major actin-binding protein, filamin, and mitotic arrest. The morphological changes of the cancer cells suggest that the AgNPs induce the cell death mechanism (Zhang et al. 2016). Figure 14.4 shows the mechanisms of AgNP-induced cytotoxicity in cancer cell-lines through endoplasmic reticulum stress (ER), lactate dehydrogenase (LDH), and ROS. Single-crystalline AgNPs have dose-dependent cytotoxic activity on the MCF-7 breast cancer cells through the induction of apoptosis, with 50% cell growth inhibition (LD50) of 3.5 ng/mL and LD100 of 14 ng/mL (Franco-Molina et al. 2010). The ROS elevation caused by the AgNPs could damage the cell DNA as reported in some in vitro studies (Ahmad et al. 2008; Asharani et al. 2009; Foldbjerg et al. 2009).
The AgNPs have shown significant inhibitory effects on the activity of interleukin-5 (IL-5), interferon-γ (INF-γ), and tumor necrosis factor-α (TNF-α) (Shin et al. 2007). The AgNPs could destroy the tumor cells because of their plasmonic nature, where the light from the target cells can be absorbed and converted into thermal energy, leading to thermal ablation of the target cells (Loo et al. 2005; Nurani et al. 2015). The AgNPs may also stimulate cytotoxicity in phagocytosing cells in mouse peritoneal macrophages and human monocytes (Foldbjerg et al. 2009; Park et al. 2010; Shavandi et al. 2011). The Cytotoxicity activity induced through ROS leading to cell apoptosis, could be achieved at a lower AgNPs concentration and low incubation times (Braydich-Stolle et al. 2005; Carlson et al. 2008; Nishanth et al. 2011). The cytotoxic effects of AgNPs on MDA-MB-231 cells, resulting in the inhibition of the cell growth, the activation of LDH, increased level of ROS generation and the activation of caspase-3, are all essentials in the induction of apoptosis (Gurunathan et al. 2013a, b). The AgNPs biosynthesized from Datura inoxia extract exhibit anticancer activity after 24 h treatment, by inducing apoptosis in the MCF-7 cells via the ROS-mediated apoptotic pathway, leading to increased ROS levels, followed by the losses of mitochondrial membrane, leading to increased apoptotic morphological changes in the AgNP-treated cells. The DNA content is significantly reduced after staining with propidium iodide (PI), where the control cells exhibit very few PI-positive cells, while the treated cells show gradual increase in the number of PI-positive cells (Gajendran et al. 2014). The Albizia adianthifolia-based AgNPs have pro-apoptotic activities which activate the intrinsic apoptotic pathway in the lung carcinoma cells (A549) mediated by the CD95 death receptor. This induces the Fas-associated protein with death domain (FADD) adapter protein which binds to and activates caspase-8 through the formation of a death-inducing signaling complex, resulting in reduced CD95 expression and ATP concentrations. The increased level of lipid peroxidation as a result of ROS is also attributable to the disorders in the mitochondrial respiratory chain (Govender et al. 2013).
14.3 Conclusion
Nanoparticles and nanomaterials can be utilized for human medical applications including for the delivery of therapeutic drugs to cells, or for the imaging of tissues and organs. AgNPs have gained special interest for biomedical applications because of their SPR energy, which is located away from the inter-band transition energy, and their antioxidant, antimicrobial, and cytotoxic activities. The development of a reliable and environmentally friendly process for the synthesis of AgNPs is of great importance, especially with regard to meeting the economic and green production route. The mechanisms of AgNP-induced bacteria death include the destruction of membrane structure and permeability via the generation of many pits and gaps, resulting in the leakage of reducing sugars and proteins. The AgNP-induced cytotoxicity in cancer cell lines is through ER stress, LDH leakage, elevated ROS and finally the induction of apoptosis.
References
Abdullah MA, Gul-e-Saba AA, Abdah A (2014) Cytotoxic effects of drug-loaded hyaluronan-glutaraldehyde cross-linked nanoparticles and the release kinetics modeling. J Adv Chem Eng 1:1000104
Abou El-Nour KMM, Eftaiha A, Al-Warthan A, Ammar RAA (2010) Synthesis and applications of silver nanoparticles. Arab J Chem 3:135–140
Ahmad A, Mukherjee P, Senapati S, Mandal D, Khan MI, Kumar R, Sastry M (2003) Extracellular biosynthesis of silver nanoparticles using the fungus Fusarium oxysporum. Colloid Surf B Biointerfaces 28:313–318
Ahmad P, Sarwat D, Sharma S (2008) Reactive oxygen species, antioxidants and signaling in plants. J Plant Biol 51:167–173
Arokiyaraj S, Arasu MV, Vincent S, Prakash NU, Choi SH, Oh YK et al (2014) Rapid green synthesis of silver nanoparticles from Chrysanthemum indicum L. and its antibacterial and cytotoxic effects: an in vitro study. Int J Nanomedicine 9:379–388
Asharani PV, Low G, Mun K, Hande MP, Valiyaveettil S (2009) Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 3:279–290
Ashokkumar S, Ravi S, Kathiravan V, Velmurugan S (2015) Synthesis of silver nanoparticles using A. indicum leaf extract and their antibacterial activity. Spectrochim Acta A Mol Biomol Spectrosc 134:34–39
Aziz N, Faraz M, Pandey R, Sakir M, Fatma T, Varma A, Barman I, Prasad R (2015) Facile algae-derived route to biogenic silver nanoparticles: synthesis, antibacterial and photocatalytic properties. Langmuir 31:11605−11612. https://doi.org/10.1021/acs.langmuir.5b03081
Aziz N, Fatma T, Varma A, Prasad R (2014) Biogenic synthesis of silver nanoparticles using Scenedesmus abundans and evaluation of their antibacterial activity. Journal of Nanoparticles, Article ID 689419, https://doi.org/10.1155/2014/689419
Aziz N, Pandey R, Barman I, Prasad R (2016) Leveraging the attributes of Mucor hiemalis-derived silver nanoparticles for a synergistic broad-spectrum antimicrobial platform. Front Microbiol 7:1984. https://doi.org/10.3389/fmicb.2016.01984
Aziz N, Faraz M, Sherwani MA, Fatma T, Prasad R (2019) Illuminating the anticancerous efficacy of a new fungal chassis for silver nanoparticle synthesis. Front Chem 7:65. https://doi.org/10.3389/fchem.2019.00065
Bai HJ, Yang BS, Chai CJ, Yang GE, Jia WL, Yi ZB (2011) Green synthesis of silver nanoparticles using Rhodobacter sphaeroides. World J Microbiol Biotechnol 27:2723–2728
Banu AN, Balasubramanian C, Moorthi PV (2014) Biosynthesis of silver nanoparticles using Bacillus thuringiensis against dengue vector, Aedes aegypti (Diptera: Culicidae). Parasitol Res 113:311–316
Braydich-Stolle L, Hussain S, Schlager JJ, Hofmann M (2005) In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci 88:412–419
Carlson C, Hussain SM, Schrand AM, Hess KL, Jones RL, Schlager JJ (2008) Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J Phys Chem B 112:13608–13619
Caroling G, Tiwari SK, Ranjitham AM, Suja R (2013) Biosynthesis of silver nanoparticles using aqueous Broccoli extract—characterization and study of antimicrobial, cytotoxic effects. Asian J Pharm Clin Res 6:165–172
Chaudhari PR, Masurkar SA, Shidore VB, Suresh P (2012) Antimicrobial activity of extracellularly synthesized silver nanoparticles using Lactobacillus species obtained from VIZYLAC capsule. J Appl Pharm Sci 2:25–29
Cheon J, Underwood HG (2009) Inorganic nanoparticles for biological sensing, imaging and therapeutics. J Mater Chem 19:6249
Choi O, Kanjun K, Kim N, Ross L, Surampalli RY, Hu Z (2008) The inhibitory effects of silver nanoparticles, silver ions, and silver chloride colloids on microbial growth. Water Res 42:3066–3074
Dakhil AS (2017) Biosynthesis of silver nanoparticle (AgNPs) using Lactobacillus and their effects on oxidative stress biomarkers in rats. J King Saud Univ-Sci 29:462–467
Daniel SCGK, Banu BN, Harshiny M, Nehru K, Sankar P, Kumaran S, Sivakumar M (2014) Ipomea carnea-based silver nanoparticle synthesis for antibacterial activity against selected human pathogens. J Exp Nanosci 9:197–209
Dash L (2013) Biological synthesis and characterization of silver nanoparticles using Bacillus thuringiensis. Dissertation, National Institute of Technology
De Jong WH, Borm PJ (2008) Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine 3(2):133–149
Debabov VG, Voeikova TA, Shebanova AS, Shaitan KV, Novikova LM, Kirpichnikov MP (2013) Bacterial synthesis of silver sulfide nanoparticles. Nanotechnol Russ 8:269–270
Devi JS, Bhimba BV (2012) Anticancer activity of silver nanoparticles synthesized by the seaweed Ulva lactuca in vitro. Sci Rep 1:242
Devi JS, Bhimba BV, Ratnam K (2012) In vitro anticancer activity of silver nanoparticles synthesized using the extract of Gelidiella sp. Int J Pharm Pharm Sci 4:710–715
Dhoondia ZH, Chakraborty H (2012) Lactobacillus mediated synthesis of silver oxide nanoparticles. Nanomater Nanotechnol 2:15
Dibrov P, Dzioba J, Gosink KK, Häse CC (2002) Chemiosmotic mechanism of antimicrobial activity of Ag+ in Vibrio cholerae. Antimicrob Agents Chemother 46:2668–2670
Dubey SP, Lahtinen M, Sillanpää M (2010) Tansy fruit mediated greener synthesis of silver and gold nanoparticles. Process Biochem 45:1065–1071
El-Kassas HY, El-Sheekh MM (2014) Cytotoxic activity of biosynthesized gold nanoparticles with an extract of the red seaweed Corallina officinalis on the MCF-7 human breast cancer cell line. Asian Pac J Cancer Prev 15:4311–4317
El-sheekh MM, El-kassas HY (2016) Algal production of nano-silver and gold: their antimicrobial and cytotoxic activities: a review. J Genet Eng Biotechnol 14:299–310
Esumi K, Tano T, Torigoe K, Meguro K (1990) Preparation and characterization of bimetallic Pd-Cu colloids by thermal decomposition of their acetate compounds in organic solvents. Chem Mater 2:564–567
Fayaz AM, Girilal M, Rahman M, Venkatesan R, Kalaichelvan PT (2011) Biosynthesis of silver and gold nanoparticles using thermophilic bacterium Geobacillus stearothermophilus. Process Biochem 46:1958–1962
Fesharaki PJ, Nazari P, Shakibaie M, Rezaie S, Banoee M, Abdollahi M, Shahverdi AR (2010) Biosynthesis of selenium nanoparticles using Klebsiella pneumoniae and their recovery by a simple sterilization process. Braz J Microbiol 41:461–466
Firdhouse MJ, Lalitha P (2013) Biosynthesis of silver nanoparticles using the extract of Alternanthera sessilis-antiproliferative effect against prostate cancer cells. Cancer Nanotechnol 4:137–143
Firdhouse MJ, Lalitha P (2015) Biosynthesis of silver nanoparticles and its applications. J Nanotechnol 2015:18
Foldbjerg R, Olesen P, Hougaard M, Anh D, Jürgen H, Autrup H (2009) PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes. Toxicol Lett 190:156–162
Franci G, Falanga A, Galdiero S, Palomba L, Rai M, Morelli G, Galdiero M (2015) Silver nanoparticles as potential antibacterial agents. Molecules 20:8856–8874
Franco-Molina MA, Mendoza-Gamboa E, Sierra-Rivera CA, Gómez-Flores RA, Zapata-Benavides P, Castillo-Tello P et al (2010) Antitumor activity of colloidal silver on MCF-7 human breast cancer cells. J Exp Clin Cancer Res 29:148
Gaidhani S, Singh R, Singh D, Patel U, Shevade K, Yeshvekar R, Chopade BA (2013) Biofilm disruption activity of silver nanoparticles synthesized by Acinetobacter calcoaceticus PUCM 1005. Mater Lett 108:324–327
Gajendran B, Chinnasamy A, Durai P, Raman J, Ramar M (2014) Biosynthesis and characterization of silver nanoparticles from Datura inoxia and its apoptotic effect on human breast cancer cell line MCF7. Mater Lett 122:98–102
Garmasheva I, Kovalenko N, Voychuk S, Ostapchuk A, Livinska O, Oleschenko L (2016) Lactobacillus species mediated synthesis of silver nanoparticles and their antibacterial activity against opportunistic pathogens in vitro. Bioimpacts 6:219–223
Gengan RM, Anand K, Phulukdaree A, Chuturgoon A (2013) A549 lung cell line activity of biosynthesized silver nanoparticles using Albizia adianthifolia leaf. Colloid Surf B Biointerfaces 105:87–91
Govender R, Phulukdaree A, Gengan RM, Anand K, Chuturgoon AA (2013) Silver nanoparticles of Albizia adianthifolia: the induction of apoptosis in human lung carcinoma cell line. J Nanobiotechnol 11:5
Gul-e-Saba, Abdullah MA (2015) Polymeric nanoparticle mediated targeted drug delivery to cancer cells. In: Thangadurai D, Sangeetha J (eds) Biotechnology and bioinformatics: advances and applications for bioenergy, bioremediation, and biopharmaceutical research. Apple Academic, Point Pleasant, NJ, pp 1–34
Gurunathan S, Kalishwaralal K, Vaidyanathan R, Venkataraman D, Pandian SRK, Muniyandi J et al (2009) Biosynthesis, purification and characterization of silver nanoparticles using Escherichia coli. Colloid Surf B Biointerfaces 74:328–335
Gurunathan S, Han J, Eppakayala V, Jeyaraj M, Kim JH (2013a) Cytotoxicity of biologically synthesized silver nanoparticles in MDA-MB-231 human breast cancer cells. Biomed Res Int 2013:10
Gurunathan S, Han JW, Dayem AA, Eppakayala V, Park JH, Cho SG et al (2013b) Green synthesis of anisotropic silver nanoparticles and its potential cytotoxicity in human breast cancer cells (MCF-7). J Ind Eng Chem 19:1600–1605
Gurunathan S, Han JW, Kwon DN, Kim JH (2014) Enhanced antibacterial and anti-biofilm activities of silver nanoparticles against Gram-negative and Gram-positive bacteria. Nanoscale Res Lett 9:373
Henglein A (1993) Physicochemical properties of small metal particles in solution: “microelectrode” reactions, chemisorption, composite metal particles, and the atom-to-metal transition. J Phys Chem 97:5457–5471
Henglein A (1998) Colloidal silver nanoparticles: photochemical preparation and interaction with O2, CCl4, and Some metal ions. Chem Mater 10:444–450
Holt KB, Bard AJ (2005) Interaction of silver (I) ions with the respiratory chain of Escherichia coli: an electrochemical and scanning electrochemical microscopy study of the antimicrobial mechanism of micromolar Ag+. Biochemistry 44:13214–13223
Hong B, Kai J, Ren Y, Han J, Zou Z, Ahn CH, Kang KA (2008) Highly sensitive rapid, reliable, and automatic cardiovascular disease diagnosis with nanoparticle fluorescence enhancer and mems. Adv Exp Med Biol 614:265–273
Hu CJ, Zhang L (2009) Therapeutic nanoparticles to combat cancer drug resistance. Curr Drug Metab 10:836–841
Hussein HA, Mohamad H, Ghazaly MM, Laith AA, Abdullah MA (2020) Cytotoxic effects of Tetraselmis suecica chloroform extracts with silver nanoparticle co-application on MCF-7, 4 T1, and Vero cell lines. Journal of Applied Phycology 32(1):127–143
Huwyler RG, Cerletti A, Fricker G, Eberle AN, Drewe J (2002) By-passing of P-glycoprotein using immunoliposomes. J Drug Target 10:73–79
Jaffat HS, Aldujaili NH, Hassan AJA (2017) Antimicrobial activity of silver nano particles biosynthesized by Lactobacillus mixtures. Res J Pharm Biol Chem Sci 8:1911–1924
Jeevan P, Ramya K, Rena AE (2012) Extracellular biosynthesis of silver nanoparticles by culture supernatant of Pseudomonas aeruginosa. Indian J Biotechnol 11:72–76
Jeyaraj M, Sathishkumar G, Sivanandhan G, MubarakAli D, Rajesh M, Arun R et al (2013) Biogenic silver nanoparticles for cancer treatment: an experimental report. Colloid Surf B Biointerfaces 106:86–92
Kalimuthu K, Suresh Babu R, Venkataraman D, Bilal M, Gurunathan S (2008) Biosynthesis of silver nanocrystals by Bacillus licheniformis. Colloid Surf B Biointerfaces 65:150–153
Kalishwaralal K, Deepak V, Ram Kumar Pandian SB, Kottaisamy M, Barath Mani Kanth S, Kartikeyan B, Gurunathan S (2010) Biosynthesis of silver and gold nanoparticles using Brevibacterium casei. Colloid Surf B Biointerfaces 77:257–262
Kalpana D, Lee YS (2013) Enzyme and microbial technology synthesis and characterization of bactericidal silver nanoparticles using cultural filtrate of simulated microgravity grown Klebsiella pneumoniae. Enzym Microb Technol 52:151–156
Kannan N, Mukunthan KS, Balaji S (2011) A comparative study of morphology, reactivity and stability of synthesized silver nanoparticles using Bacillus subtilis and Catharanthus roseus (L.) G. Don. Colloids Surf B Biointerfaces 86:378–383
Karimzadeh R, Mansour N (2010) The effect of concentration on the thermo-optical properties of colloidal silver nanoparticles. Opt Laser Technol 42:783–789
Karthik C, Radha KV (2012) Biosynthesis and characterization of silver nanoparticles using Enterobacter aerogenes: a kinetic approach. Dig J Nanomater Biostr 7:1007–1014
Kasthuri J, Veerapandian S, Rajendiran N (2009) Biological synthesis of silver and gold nanoparticles using apiin as reducing agent. Colloids Surf B Biointerfaces 68:55–60
Kim JS, Kuk E, Yu N, Kim J, Park SJ, Lee J et al (2007) Antimicrobial effects of silver nanoparticles. Nanomedicine 3:95–101
Klaus T, Joerger R, Olsson E, Granqvist C-G (1999) Silver-based crystalline nanoparticles, microbially fabricated. Proc Natl Acad Sci U S A 96:13611–13614
Klaus-Joerger T, Joerger R, Olsson E, Granqvist CG (2001) Bacteria as workers in the living factory: metal-accumu-lating bacteria and their potential for materials science. Trends Biotechnol 19:15–20
Krishnamurthy S, Yun YS (2013) Recovery of microbially synthesized gold nanoparticles using sodium citrate and detergents. Chem Eng J 214:253–261
Krishnaraj RN, Berchmans S (2013) In-vitro antiplatelet activity of silver nanoparticles synthesized using the microorganism Gluconobacter roseus: AFM based study. RSC Adv 3:8953–8959
Krishnaraj C, Muthukumaran P, Ramachandran R, Balakumaran MD, Kalaichelvan PT (2014) Acalypha indica Linn: biogenic synthesis of silver and gold nanoparticles and their cytotoxic effects against MDA-MB-231, human breast cancer cells. Biotechnol Rep 4:42–49
Kumar CG, Mamidyala SK (2011) Colloids and surfaces B: biointerfaces extracellular synthesis of silver nanoparticles using culture supernatant of Pseudomonas aeruginosa. Colloids Surf B Biointerfaces 84:462–466
Lammers T, Kiessling F, Hennink WE, Storm G (2012) Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. J Control Release 161:175–187
Law N, Ansari S, Livens FR, Renshaw JC, Lloyd JR (2008) Formation of nanoscale elemental silver particles via enzymatic reduction by Geobacter sulfurreducens. Appl Environ Microbiol 74:7090–7093
Li Y, Duan X, Qian Y, Yang L, Liao H (1999) Nanocrystalline silver particles: synthesis, agglomeration, and sputtering induced by electron beam. J Colloid Interface Sci 209:347–349
Li WR, Xie XB, Shi QS, Zeng HY, Ou-Yang YS, Chen YB (2010) Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli. Appl Microbiol Biotechnol 85:1115–1122
Liz-Marzán LM, Lado-Touriño I (1996) Reduction and stabilization of silver nanoparticles in ethanol by nonionic surfactants. Langmuir 12:3585–3589
Loo C, Lowery A, Halas N, West J, Drezek R (2005) Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett 5:709–711
Minchinton AI, Tannock IF (2006) Drug penetration in solid tumours. Nat Rev Cancer 6:583–592
Mouxhg FU, Qingbiao LI, Daohua SUN, Yinghua PLU, Ning H, Xu D et al (2006) Rapid preparation process of silver nanoparticles by bioreduction and their characterizations. Chin J Chem Eng 14:114–117
Nabikhan A, Kandasamy K, Raj A, Alikunhi NM (2010) Synthesis of antimicrobial silver nanoparticles by callus and leaf extracts from saltmarsh plant, Sesuvium portulacastrum L. Colloids Surf B Biointerfaces 79:488–493
Nanda A, Saravanan M (2009) Biosynthesis of silver nanoparticles from Staphylococcus aureus and its antimicrobial activity against MRSA and MRSE. Nanomedicine 5:452–456
Narayanan KB, Sakthivel N (2013) Biosynthesis of silver nanoparticles by phytopathogen Xanthomonas oryzae pv. oryzae Strain BXO8. J Microbiol Biotechnol 23:1287–1288
Ninganagouda S, Rathod V, Singh D, Hiremath J, Singh AK, Mathew J, Ul-Haq M (2014) Growth kinetics and mechanistic action of reactive oxygen species released by silver nanoparticles from Aspergillus niger on Escherichia coli. Biomed Res Int 2014:1–9
Niraimathi KL, Sudha V, Lavanya R, Brindha P (2013) Biosynthesis of silver nanoparticles using Alternanthera sessilis (Linn.) extract and their antimicrobial, antioxidant activities. Colloids Surf B Biointerfaces 102:288–291
Nishanth RP, Jyotsna RG, Schlager JJ, Hussain SM, Reddanna P (2011) Inflammatory responses of RAW 264.7 macrophages upon exposure to nanoparticles: role of ROS-NFκB signaling pathway. Nanotoxicology 5:502–516
Nithya R, Ragunathan R (2012) Synthesis of silver nanoparticles using a probiotic microbe and its antibacterial effect against multidrug resistant bacteria. Afr J Biotechnol 11:11013–11021
Nurani SJ, Saha KC, Rahman Khan MA, Sunny SMH (2015) Silver nanoparticles synthesis, properties, applications and future perspectives: a short review. IOSR J Electr Electron Eng 10:117–126
Okafor F, Janen A, Kukhtareva T, Edwards V, Curley M (2013) Green synthesis of silver nanoparticles, their characterization, application and antibacterial activity. Int J Environ Res Public Health 10:5221–5238
Omidi B, Hashemi SJ, Bayat M, Larijani K (2014) Biosynthesis of silver nanoparticles by Lactobacillus fermentum. Bull Environ Pharmacol Life Sci 3:186–192
Otari SV, Patil RM, Nadaf NH, Ghosh SJ, Pawar SH (2014) Green synthesis of silver nanoparticles by microorganism using organic pollutant: its antimicrobial and catalytic application. Environ Sci Pollut Res 21:1503–1513
Oves M, Khan MS, Zaidi A, Ahmed AS, Ahmed F, Ahmad E et al (2013) Antibacterial and cytotoxic efficacy of extracellular silver nanoparticles biofabricated from chromium reducing novel OS4 strain of Stenotrophomonas maltophilia. PLoS One 8:e59140
Parikh RY, Ramanathan R, Coloe PJ, Bhargava SK, Patole MS, Shouche YS, Bansal V (2011) Genus-wide physicochemical evidence of extracellular crystalline silver nanoparticles biosynthesis by Morganella spp. PLoS One 6:e21401
Park E, Yi J, Kim Y, Choi K, Park K (2010) Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism. Toxicol Vitr 24:872–878
Patil MP, Kim G (2017) Eco-friendly approach for nanoparticles synthesis and mechanism behind antibacterial activity of silver and anticancer activity of gold nanoparticles. Appl Microbiol Biotechnol 101:79–92
Patil SV, Borase HP, Patil CD, Salunke BK (2012) Biosynthesis of silver nanoparticles using latex from few euphorbian plants and their antimicrobial potential. Appl Biochem Biotechnol 167:776–790
Paulkumar K, Rajeshkumar S, Gnanajobitha G, Vanaja M, Malarkodi C, Annadurai G (2013) Biosynthesis of silver chloride nanoparticles using Bacillus subtilis MTCC 3053 and assessment of its antifungal activity. ISRN Nanomater 2013:8
Pileni MP (2000) Fabrication and physical properties of self-organized silver nanocrystals. Pure Appl Chem 72:53–65
Prasad R (2014) Synthesis of silver nanoparticles in photosynthetic plants. Journal of Nanoparticles, Article ID 963961, http://dx.doi.org/10.1155/2014/963961
Prasad R, Pandey R, Barman I (2016) Engineering tailored nanoparticles with microbes: quo vadis. WIREs Nanomed Nanobiotechnol 8:316–330. https://doi.org/10.1002/wnan.1363
Prasad R, Jha A, Prasad K (2018) Exploring the realms of nature for nanosynthesis. Springer International Publishing (ISBN 978-3-319-99570-0) https://www.springer.com/978-3-319-99570-0
Pugazhenthiran N, Anandan S, Kathiravan G, Prakash NKU, Crawford S, Ashokkumar M (2009) Microbial synthesis of silver nanoparticles by Bacillus sp. J Nanopart Res 11:1811–1815
Radzig MA, Nadtochenko VA, Koksharova OA, Kiwi J, Lipasova VA, Khmel IA (2013) Antibacterial effects of silver nanoparticles on Gram-negative bacteria: influence on the growth and biofilms formation, mechanisms of action. Colloids Surf B Biointerfaces 102:300–306
Rai M, Yadav A, Gade A (2009) Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 27:76–83
Rajasekharreddy P, Rani PU (2014) Biofabrication of Ag nanoparticles using Sterculia foetida L. seed extract and their toxic potential against mosquito vectors and HeLa cancer cells. Mater Sci Eng C 39:203–212
Rajeshkumar S, Malarkodi C, Paulkuma K, Vanaja M, Gnanajobitha G, Annadurai G (2013) Intracellular and extracellular biosynthesis of silver nanoparticles by using marine bacteria Vibrio alginolyticus. Nanosci Nanotechnol 3:21–25
Ramanathan R, Mullane APO, Parikh RY, Smooker PM, Bhargava SK, Bansal V (2011) Bacterial kinetics-controlled shape-directed biosynthesis of silver nanoplates using Morganella psychrotolerans. Langmuir 27:714–719
Rosarin FS, Arulmozhi V, Nagarajan S, Mirunalini S (2013) Antiproliferative effect of silver nanoparticles synthesized using amla on Hep2 cell line. Asian Pac J Trop Med 6:1–10
Samadi N, Golkaran D, Eslamifar A, Jamalifar H, Fazeli MR, Mohseni FA (2009) Intra/extracellular biosynthesis of silver nanoparticles by an autochthonous strain of Proteus mirabilis isolated from photographic waste. J Biomed Nanotechnol 5:247–253
Sankar R, Karthik A, Prabu A, Karthik S, Shivashangari KS, Ravikumar V (2013) Origanum vulgare mediated biosynthesis of silver nanoparticles for its antibacterial and anticancer activity. Colloids Surf B Biointerfaces 108:80–84
Sathishkumar G, Gobinath C, Wilson A, Sivaramakrishnan S (2014) Dendrophthoe falcata (L.f) Ettingsh (Neem mistletoe): a potent bioresource to fabricate silver nanoparticles for anticancer effect against human breast cancer cells (MCF-7). Spectrochim Acta A Mol Biomol Spectrosc 128:285–290
Schlinkert P, Casals E, Boyles M, Tischler U, Hornig E, Tran N et al (2015) The oxidative potential of differently charged silver and gold nanoparticles on three human lung epithelial cell types. J Nanobiotechnol 13:1–18
Seshadri S, Prakash A, Kowshik M (2012) Biosynthesis of silver nanoparticles by marine bacterium, Idiomarina sp. PR58–8. Bull Mater Sci 35:1201–1205
Seth D, Roy S, Saheli C, Gupta S, Palit D, Das S et al (2011) Nature-inspired novel drug design paradigm using nanosilver: efficacy on multi-drug-resistant clinical isolates of tuberculosis. Curr Microbiol 62:715–726
Shahverdi AR, Fakhimi A, Shahverdi HR, Minaian S (2007) Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. Nanomedicine 3:168–171
Shavandi Z, Ghazanfari T, Moghaddam KN (2011) In vitro toxicity of silver nanoparticles on murine peritoneal macrophages. Immunopharmacol Immunotoxicol 33:135–140
Shawkey AM, Rabeh MA, Abdulall AK, Abdellatif AO (2013) Green nanotechnology: anticancer activity of silver nanoparticles using Citrullus colocynthis aqueous extracts. Adv Life Sci Technol 13:60–71
Shin S, Ye M, Kim H, Kang H (2007) The effects of nano-silver on the proliferation and cytokine expression by peripheral blood mononuclear cells. Int Immunopharmacol 7:1813–1818
Singh R, Wagh P, Wadhwani S, Gaidhani S, Kumbhar A, Bellare J, Chopade BA (2013) Synthesis, optimization, and characterization of silver nanoparticles from Acinetobacter calcoaceticus and their enhanced antibacterial activity when combined with antibiotics. Int J Nanomedicine 8:4277–4290
Singh R, Shedbalkar UUA, Wadhwani S, Chopade BA (2015) Bacteriagenic silver nanoparticles: synthesis, mechanism, and applications. Appl Microbiol Biotechnol 99:4579–4593
Sintubin L, De Windt W, Dick J, Mast J, Van Der Ha D, Verstraete W, Boon N (2009) Lactic acid bacteria as reducing and capping agent for the fast and efficient production of silver nanoparticles. Appl Microbiol Biotechnol 84:741–749
Srivastava SK, Constanti M (2012) Room temperature biogenic synthesis of multiple nanoparticles (Ag, Pd, Fe, Rh, Ni, Ru, Pt, Co, and Li) by Pseudomonas aeruginosa SM1. J Nanopart Res 14:831
Suman TY, Radhika Rajasree SR, Kanchana A, Elizabeth SB (2013) Biosynthesis, characterization and cytotoxic effect of plant mediated silver nanoparticles using Morinda citrifolia root extract. Colloids Surf B Biointerfaces 106:74–78
Sun YP, Atorngitjawat P, Meziani MJ (2001) Preparation of silver nanoparticles via rapid expansion of water in carbon dioxide microemulsion into reductant solution. Langmuir 17:5707–5710
Supraja S, Arumugam P (2015) Antibacterial and anticancer activity of silver nanoparticles synthesized from Cynodon dactylon leaf extract. J Acad Ind Res 3:629–631
Supraja N, Prasad TNVKV, Soundariya M, Babujanarthanam R (2016) Synthesis, characterization and dose dependent antimicrobial and anti-cancerous activity of phycogenic silver nanoparticles against human hepatic carcinoma (HepG2) cell line. AIMS Bioeng 3:425–440
Suresh AK, Pelletier DA, Wang W, Morrell-Falvey JL, Gu B, Doktycz MJ (2012) Cytotoxicity induced by engineered silver nanocrystallites is dependent on surface coatings and cell types. Langmuir 28:2727–2735
Tabata Y, Ikada Y (1988) Macrophage phagocytosis of biodegradable microspheres composed of L-lactic acidlglycolic acid homo- and copolymers. J Biomed Mater Res 22:837–858
Tamboli DP, Lee DS (2013) Mechanistic antimicrobial approach of extracellularly-synthesized silver nanoparticles against Gram positive and Gram negative bacteria. J Hazard Mater 260:878–884
Tan Y, Dai X, Zhu D (2003) Preparation of gold, platinum, palladium and silver nanoparticles by the reduction of their salts with a weak reductant–potassium bitartrate. J Mater Chem 13:1069–1075
Tanja Klaus-Joerger, Ralph Joerger, Eva Olsson, Claes-Göran Granqvist, (2001) Bacteria as workers in the living factory: metal-accumulating bacteria and their potential for materials science. Trends in Biotechnology 19 (1):15–20
Thakkar KN, Mhatre SS, Parikh RY (2010) Biological synthesis of metallic nanoparticles. Nanomedicine 6:257–262
Thakur VK, Thakur MK, Gupta RK (2014) Review: raw natural fiber–based polymer composites. Int J Polym Anal Charact 19:256–271
Thomas R, Jasim B, Mathew J, Radhakrishnan E (2012) Extracellular synthesis of silver nanoparticles by endophytic Bordetella sp. isolated from Piper nigrum and its antibacterial activity analysis. Nano Biomed Eng 4:183–187
Tiyaboonchai W (2003) Chitosan nanoparticles: a promising system for drug delivery. Naresuan Univ J11:51–66
Valodkar M, Jadeja RN, Thounaojam MC, Devkar RV, Thakore S (2011) In vitro toxicity study of plant latex capped silver nanoparticles in human lung carcinoma cells. Mater Sci Eng C 31:1723–1728
Vijayakumar M, Priya K, Nancy FT, Noorlidah A, Ahmed ABA (2013) Biosynthesis, characterization an anti-bacterial effect of plant mediated silver nanoparticles using Artemisia nilagirica. Ind Crop Prod 41:235–240
Wicki A, Witzigmann D, Balasubramanian V, Huwyler J (2015) Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. J Control Release 200:138–157
Xu H, Yao L, Sun H, Wu Y (2009) Chemical composition and antitumor activity of different polysaccharides from the roots of Actinidia eriantha. Carbohydr Polym 78:316–322
Yazdi MH, Mahdavi M, Faghfuri E, Faramarzi MA, Sepehrizadeh Z, Faramarzi MA et al (2015) Th1 immune response induction by biogenic selenium nanoparticles in mice with breast cancer: preliminary vaccine model. Iran J Biotechnol 13:1–9
Zewde B, Ambaye A, Stubbs JI, Dharmara R (2016) A review of stabilized silver nanoparticles – synthesis, biological properties, characterization, and potential areas of applications. JSM Nanotechnol Nanomed 4:1043
Zhang H, Li Q, Lu Y, Sun D, Lin X, Deng X et al (2005) Biosorption and bioreduction of diamine silver complex by Corynebacterium. J Chem Technol Biotechnol 80:285–290
Zhang L, Gu F, Chan J, Wang A, Langer R, Farokhzad O (2008) Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther 8:761–769
Zhang J, Chen XG, Sun GZ, Huang L, Cheng XJ (2010a) Effect of molecular weight on the oleoyl-chitosan nanoparticles as carriers for doxorubicin. Colloids Surf B Biointerfaces 77:125–130
Zhang Y, Yang D, Kong Y, Wang X, Pandoli O, Gao G (2010b) Synergetic antibacterial effects of silver nanoparticles @ Aloe vera prepared via a green method. Nano Biomed Eng 2:267–274
Zhang D, Sun P, Li P, Xue A, Zhang X, Zhang H, Jin X (2013) A magnetic chitosan hydrogel for sustained and prolonged delivery of Bacillus Calmette–Guérin in the treatment of bladder cancer. Biomaterials 34:10258–10266
Zhang X, Liu ZG, Shen W, Gurunathan S (2016) Silver nanoparticles: synthesis, characterization, properties, applications, and therapeutic approaches. Int J Mol Sci 17:1534
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Hussein, H.A., Abdullah, M.A. (2020). Biosynthesis, Mechanisms, and Biomedical Applications of Silver Nanoparticles. In: Thangadurai, D., Sangeetha, J., Prasad, R. (eds) Functional Bionanomaterials. Nanotechnology in the Life Sciences. Springer, Cham. https://doi.org/10.1007/978-3-030-41464-1_14
Download citation
DOI: https://doi.org/10.1007/978-3-030-41464-1_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-41463-4
Online ISBN: 978-3-030-41464-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)